To gain greater understanding of genetic control mechanisms that establish phenotypic diversity among striated myocytes, we have studied the regulation of myoglobin gene expression during embryonic development, during the transition from fetal to post-natal life, and during fast-to- slow fiber transformation induced in adult skeletal muscles by motor nerve stimulation. Work performed in the previous project period has placed us now in a position to elucidate in detail biochemical events responsible for transcriptional control of the myoglobin gene. We have defined upstream activation sequences (CCAC and A/T motifs) that function synergistically in transcriptional activation of the myoglobin gene during cardiac and skeletal muscle development. In addition, we have identified cognate proteins that bind DNA at these critical motifs. These include novel proteins (CBF40, ATF35, and MNF), as well as previously described transcription factors (MEF2, Sp1). We will address three specific aims.
Specific aim (1): To identify the DNA binding proteins necessary for functional activity of the myoglobin muscle-specific enhancer. Of five protein factors present in crude myotube or cardiomyocyte extracts that bind the CCAC or A/T regions, 3 have been isolated as cDNA clones by ourselves (MNF) or others (MEF2, 5p 1), while 2 others--CBF4O and ATF35-- have not yet been characterized fully. We expect to isolate 4cDNA clones encoding these remaining proteins, and then, by a combination of gain-of- function and loss-of-function strategies, to define the relative importance of each of these 4 factors for transcriptional activity of the myoglobin gene in cardiac and skeletal myocytes.
Specific aim (2): To define the molecular basis for selective expression of myoglobin in red, oxidative skeletal myofibers. Synergistic interactions between factors binding the CCAC box and A/T motifs are required for transcriptional activity of the myoglobin promoter/enhancer. We will test the hypothesis that differential expression or activity of one or more of the proteins, or of other coactivators that form protein-protein contacts with these DNA-binding proteins, provides the basis for the selective expression of myoglobin in Type I and Type IIa myofibers.
Specific aim (3): To define the functional roles of MNFs in muscle development. Our working hypothesis is that MNFs are physiological regulators of myoglobin gene expression. We are eager, however, to define other functions of these novel proteins. We propose to define spatial and temporal patterns of expression of MNFs during fetal and post-natal development, to disrupt the MNF gene and to define the resulting phenotype, to define consensus binding sites for MNFs, which should lead to the identification of other genes activated by MNF. These studies, in aggregate, have excellent potential for defining molecular details of myoglobin enhancer function at high resolution, and provide opportunities to define the functions of novel and interesting transcription factors. We expect these experiments to elucidate general mechanisms by which the distinctive phenotypes of red and white skeletal myofibers are established and maintained.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040849-07
Application #
2683292
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1991-04-01
Project End
2001-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Stiber, Jonathan A; Tabatabaei, Niloufar; Hawkins, April F et al. (2005) Homer modulates NFAT-dependent signaling during muscle differentiation. Dev Biol 287:213-24
Akimoto, Takayuki; Ribar, Thomas J; Williams, R Sanders et al. (2004) Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice. Am J Physiol Cell Physiol 287:C1311-9
Rothermel, Beverly A; Vega, Rick B; Williams, R Sanders (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15-21
Yan, Zhen; Choi, Sangdun; Liu, Xuebin et al. (2003) Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278:8826-36
Williams, R S; Rosenberg, P (2002) Calcium-dependent gene regulation in myocyte hypertrophy and remodeling. Cold Spring Harb Symp Quant Biol 67:339-44
Wu, Hai; Kanatous, Shane B; Thurmond, Frederick A et al. (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296:349-52
Vega, Rick B; Yang, John; Rothermel, Beverly A et al. (2002) Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277:30401-7
Meeson, A P; Radford, N; Shelton, J M et al. (2001) Adaptive mechanisms that preserve cardiac function in mice without myoglobin. Circ Res 88:713-20
Rothermel, B A; McKinsey, T A; Vega, R B et al. (2001) Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 98:3328-33
Grange, R W; Meeson, A; Chin, E et al. (2001) Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice. Am J Physiol Cell Physiol 281:C1487-94

Showing the most recent 10 out of 21 publications